Abstract:BACKGROUND: The chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like gene (CHD1L) is a recently identified oncogene localized at 1q21. CHD1L protein over-expression in primary hepatocellular carcinoma is correlated with enhanced apoptosis inhibition, reduced chemosensitivity and shortened patient survival. However, CHD1L protein status or mRNA expression in breast cancer and its clinical significance remain obscure.MATERIAL AND METHODS: In this study, immunohistochemical staining for CHD1L expression was performed on tissue microarrays containing 179 primary invasive breast cancers and 65 matched normal breast tissue specimens. Clinico-pathological features were collected and compared between different CHD1L statuses. Kaplan-Meier curves were applied to estimate disease-free survival (DFS) and overall survival (OS). Cox regression was used to identify independent prognostic factors. Also, quantitative real-time polymerase chain reaction (QRT-PCR) was employed to evaluate the mRNA level expression of CHD1L in six breast cancer cell lines.RESULTS: Presence of CHD1L over-expression was observed in 87 of the 179 patients (48.6%), which associated with a younger age (P = 0.011), higher grade (P = 0.004), higher Ki-67 index (P = 0.018) and HER2 over-expression/amplification (P = 0.037). After a median follow-up of 55 months, patients with presence of CHD1L over-expression had significantly poorer DFS (82.6% Vs 76.3%, P = 0.035), but not OS (87.0% Vs 94.9%, P = 0.439). In multivariate analysis, CHD1L status (HR = 2.169, [95%CI, 1.029-4.573], P = 0.042), triple negative subtype (HR = 2.809, [95%CI 1.086-7.264], P = 0.033) and HER2 positive subtype (HR = 5.221, [95%CI 1.788-15.240], P = 0.002) were identified as independent prognostic factors for DFS. In vitro study indicated that relative mRNA expression level of CHD1L was higher in breast cancer cell lines, especially in MDA-MB-231 and LM2-4175, when compared to normal breast epithelial cell line.CONCLUSIONS: Presence of CHD1L over-expression is probably associated with aggressive tumor biology in breast cancer. CHD1L status might be a novel prognostic biomarker for patients with breast cancer.

Lamin B1 Overexpression Promotes Breast Cancer Growth Via Increasing H3K9ac Modification Through HDAC2 Inhibition

Lamin B2 promotes the malignant phenotype of non-small cell lung cancer cells by upregulating dimethylation of histone 3 lysine 9

Expression of Lamin A/C in early-stage breast cancer and its prognostic value

Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma

Expression of the laminin genes family and its relationship to prognosis in pancreatic carcinoma

Overexpression of LAMC2 Predicts Poor Prognosis in Colorectal Cancer Patients and Promotes Cancer Cell Proliferation, Migration, and Invasion.

Low lamin A levels enhance confined cell migration and metastatic capacity in breast cancer

Overexpression of Β3 Chains of Laminin-332 is Associated with Clinicopathologic Features and Decreased Survival in Patients with Pancreatic Adenocarcinoma.

LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer

ZNF133 is a Potent Suppressor in Breast Carcinogenesis Through Dampening L1CAM, a Driver for Tumor Progression

Lamin B1 Tethers To Chromatin And Organizes Its High-Order Structure

ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor cell invasion

Mechanism and role of nuclear laminin B1 in cell senescence and malignant tumors

Lamins regulate nuclear mechanics and shape to control glioblastoma cell proliferation, migration and invasion

Overexpression of Α3, Β3 and Γ2 Chains of Laminin-332 is Associated with Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

HIF-1α-mediated LAMC1 overexpression is an unfavorable predictor of prognosis for glioma patients: evidence from pan-cancer analysis and validation experiments

Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer

NAP1L1 interacts with hepatoma-derived growth factor to recruit c-Jun inducing breast cancer growth

The Differential Expression of LaminA/C in Normal Human Breast Tissue and in Breast Carcinoma Tissue

Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway

Presence of CHD1L Over-Expression Is Associated with Aggressive Tumor Biology and Is a Novel Prognostic Biomarker for Patient Survival in Human Breast Cancer